<DOC>
	<DOCNO>NCT03085836</DOCNO>
	<brief_summary>The purpose study determine pharmacokinetics ( PK ) TAK-438 healthy adult Chinese participant single multiple dose administration .</brief_summary>
	<brief_title>A Pharmacokinetic Study TAK-438 Healthy Adult Chinese Participants</brief_title>
	<detailed_description>The drug test study call TAK-438 . TAK-438 test healthy participant order evaluate PK single multiple oral dose . The study enroll approximately 36 healthy participant . Participants assign one three treatment group : - TAK-438 10 mg tablet QD - TAK-438 20 mg tablet QD - TAK-438 20 mg tablet BID All participant ask take TAK-438 tablet time Day 1 Days 3-9 . This single-centre trial conduct China . The overall time participate study 18 day . Participants remain confined clinic Day 1 Day 11 followed-up telephone visit Day 18 .</detailed_description>
	<criteria>1 . Is healthy adult male female Chinese participant . 2 . Is age 18 45 year , inclusive , time signing informed consent form . 3 . Weighs least 50 kilogram ( kg ) body mass index ( BMI ) 19 26 kilogram per square meter ( kg/m^2 ) , inclusive Screening ( CheckIn Day 1 ) . 4 . Is willing abstain caffeine alcohol 72 hour first dose ( Day 1 ) Followup Visit Day 18 . 5 . Is willing abstain strenuous exercise 72 hour first dose ( Day 1 ) Followup Visit Day 18 . 6 . Is willing provide sample pharmacogenetic analysis ( CYP2C19 genotyping ) . 1 . Has uncontrolled , clinically significant cardiovascular disease abnormality , may impact ability participant participate potentially confound study result . 2 . Is lactose intolerant know hypersensitivity component formulation TAK438 . 3 . Has poor peripheral venous access . 4 . Has donate lose 400 milliliter ( mL ) blood volume ( include plasmapheresis ) , transfusion blood product within 90 day prior Day 1 ; participant donate lose 200 mL blood last 28 day . 5 . Has history symptomatic GERD , GERD , Erosive Esophagitis , DU , GU , dyspepsia , Barrett 's Esophagus , ZollingerEllison ( ZE ) syndrome current recent ( within 6 month ) gastrointestinal disease would expect influence absorption drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Drug Therapy</keyword>
</DOC>